PATENT CLAIM ANALYSIS

Application Number: 16271332
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to methods and/or uses for treating pancreatitis, kidney diseases and other various disorders as described herein, for conditions or disorders mediated by KMO inhibitors, which comprises administering 6-chlorobenzoxazine compounds of Formula (I): or pharmaceutically acceptable salts and/or corresponding pharmaceutical compositions thereof.

Claim (Index 9):
The method for treating pancreatitis according to  claim 1 , wherein the pancreatitis is acute pancreatitis.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 99.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15574947', '15537805', '15698435', '15900043', '15103409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.79115696663267
- 35 USC 102 Novelty (BERT): 0.5965923584755531
- Combined Prediction Score: 0.7717005058169583
- Mean Citation Score: 430.932902
- Max Citation Score: 578.8304
- Similarity Product: 403.7680094406128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test